Cardiovascular disease in the antiphospholipid syndrome

Jenny Amaya-Amaya1, Adriana Rojas-Villarraga1, Juan-Manuel Anaya2

  • 1Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia; and Mederi, Hospital Universitario Mayor, Bogotá, Colombia.

Lupus
|September 18, 2014
PubMed

Insights

Cardiovascular disease (CVD) in antiphospholipid syndrome (APS) is influenced by various factors beyond traditional risks. Novel risk factors contribute significantly to premature CVD and vascular damage in APS patients.

Area of Science:

  • Rheumatology
  • Cardiology
  • Immunology

Background:

  • Antiphospholipid syndrome (APS) is associated with a high prevalence of cardiovascular disease (CVD).
  • The exact prevalence and causes of CVD in APS are not fully understood and vary based on detection methods.
  • Atherosclerosis, a key driver of CVD, involves endothelial damage and is considered an autoimmune-inflammatory process.

Purpose of the Study:

  • To review the significance and outcomes of cardiovascular disease (CVD) in patients with antiphospholipid syndrome (APS).
  • To explore the contribution of novel risk factors to premature CVD in APS.
  • To understand the mechanisms of accelerated vascular damage in APS.

Main Methods:

  • Literature review of studies on CVD in APS.
  • Analysis of diagnostic criteria and detection tools for CVD in APS cohorts.
  • Examination of traditional and novel cardiovascular risk factors in APS patients.

Main Results:

  • CVD prevalence in APS varies significantly across studies.
  • Traditional risk factors do not fully explain the excess cardiovascular events in APS.
  • Novel risk factors play a crucial role in the development of premature CVD and vascular damage in APS.

Conclusions:

  • Cardiovascular disease is a major concern in antiphospholipid syndrome.
  • Understanding novel risk factors is essential for managing CVD in APS.
  • Further research is needed to elucidate the complex relationship between APS and cardiovascular outcomes.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
653
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
649
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
755
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
838